Epredia™ Lab Vision™ CA19-9/Sialyl Lewisa (GI Tumor Marker) Ab-1 Mouse Monoclonal Antibody, 200µg/mL, BSA and azide
Obtain accurate, reproducible results in immunohistochemistry procedures with Epredia™ CA19-9/Sialyl Lewisa (GI Tumor Marker) Ab-1, Mouse Monoclonal Antibody.
Marca: Epredia™ MS-379-P
Detalles adicionales : Peso : 0.00250kg
DescripciónMucin glycoprotein is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues, sialyl Lewisa antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings.
Host Species: Mouse
Species Reactivity: Human. Does not react with rat. Others not tested.
Immunogen: Mucins from ovarian cyst
Molecular Weight: >400kDa
Positive Control: Colon CA
Cellular Localization: Cytoplasmic
- Immunohistochemistry (Formalin/paraffin)
|CA19-9/Sialyl Lewissuperscriptasuperscript (GI Tumor Marker) Ab-1|
|Purified Ab with BSA and Azide|
|Mucins from ovarian cyst|